Baker McKenzie has advised Ally Bridge Group (ABG) in the framework of a Series A investment, the first round of a total of $50 million in fundraising, in Quantum Surgical, an innovative French surgical robotics company.
Ally Bridge Group is an investment firm which specialises in life sciences. ABG and its affiliates manage over $ 2 billion in life science assets in China, the U.S., and Europe, from medtech to biopharmaceuticals, and continues to invest in the most innovative medical solutions.
Created in 2017 and based in Montpellier, Quantum Surgical is a French start-up created by Bertin Nahum which specialises in the development of next generation robotics solutions for minimally invasive cancer therapies.
Lifetech Scientific, a leading innovative medical technology company in China, also participated in this investment through its joint venture with ABG and will work with Quantum Surgical on the Chinese market.
Baker McKenzie advised ABG with Matthieu Grollemund, partner with the M&A practice in Paris, and Raphaël Sendowski, associate.